EMVision

Country:
Australia
Founding year:
2017

EMVision is a neurotechnology company developing portable brain imaging devices based on electromagnetic imaging to support rapid neurological diagnosis. The company focuses on enabling earlier detection and differentiation of stroke types outside of traditional hospital imaging suites.

Its platform uses low-energy electromagnetic waves and advanced reconstruction algorithms to generate brain images that can identify conditions such as ischemic and hemorrhagic stroke. The system is designed to be mobile, fast to deploy, and suitable for use in pre-hospital and emergency care environments.

EMVision’s technology is intended for use by emergency medical services, hospitals, and acute care teams to accelerate triage and treatment decisions. The company positions its system as a complementary neuroimaging modality that expands access to brain imaging in time-critical settings.

Neuroimaging
Diagnostics
Clinical Workflows

Neurofounders Insights

Modality:
Others
Form Factor:
Imaging system
Interface Depth:
Non-invasive
Indication:
Stroke
Target user:
Clinicians
Regulatory stage:
Investigational

Public

EMVision is developing portable electromagnetic imaging for stroke diagnosis, offering a radiation-free alternative to CT. Its point-of-care focus targets emergency settings, though it remains in the investigational stage.

Related companies

Articles featuring

EMVision

No articles yet!

Press releases

No press releases published yet.